Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for International Biotechnology Trust's FCF Margin % or its related term are showing as below:
LSE:IBT'
s FCF Margin % Range Over the Past 10 Years
Min: -16361.71 Med: -11.41 Max: 321.39
Current: 48.81
During the past 13 years, the highest FCF Margin % of International Biotechnology Trust was 321.39%. The lowest was -16361.71%. And the median was -11.41%.
LSE:IBT's FCF Margin % is ranked better than 96.53% of 950
companies
in the Biotechnology industry
Industry Median: -81.28
vs LSE:IBT: 48.81
International Biotechnology Trust FCF Margin % Related Terms
International Biotechnology Trust FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
International Biotechnology Trust FCF Margin % Chart
LSE:IBT vs VRTX, REGN, RVMD: FCF Margin % Comparison
For the Biotechnology subindustry, International Biotechnology Trust's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
International Biotechnology Trust FCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, International Biotechnology Trust's FCF Margin % distribution charts can be found below:
* The bar in red indicates where International Biotechnology Trust's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
International Biotechnology Trust (LSE:IBT) has a FCF Margin % of 7.60% as of Feb. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on International Biotechnology Trust and its competitors. According to the industry distribution chart, International Biotechnology Trust ranks #33 out of 950 companies in the Biotechnology industry, placing it in the top 3.5%.
Is International Biotechnology Trust's FCF Margin % too high?
International Biotechnology Trust's current FCF Margin % is 7.60%. Based on the distribution chart, International Biotechnology Trust ranks #33 out of 950 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, International Biotechnology Trust has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does International Biotechnology Trust's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, International Biotechnology Trust ranks #33 out of 950 companies for FCF Margin %. This places International Biotechnology Trust in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on International Biotechnology Trust and its competitors. International Biotechnology Trust's current FCF Margin % is 7.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is International Biotechnology Trust stock overvalued right now?
International Biotechnology Trust (LSE:IBT) has a current FCF Margin % of 7.60%. The current FCF Margin % is 7.60%. International Biotechnology Trust's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For International Biotechnology Trust (LSE:IBT), the current FCF Margin % is 7.60% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
International Biotechnology Trust Business Description
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments ,and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.
36GF Score
Get the complete analysis for LSE:IBT
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:IBT has been successfully added to your 
